IP Library Granted Patent US 7,160,719
Granted Patent B2
US 7,160,719 · App. 10/164,817 · Granted Jan 9, 2007

Bioartificial liver system

Assignee: Mayo Foundation for Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,160,719
App. No.
10/164,817
Granted
Jan 9, 2007
Kind
B2
Abstract

A bioartificial liver system is described that incorporates a cell reservoir and hepatocyte spheroids to both increase the number of and longevity of cells in the system. Additional methods are also described for forming spheroid aggregates from isolated hepatocytes.

Claims (14)

1. A system for treating blood or plasma from a mammal, said system comprising:

a) a bioreactor comprising a selectively permeable baffler separating a fluid treatment compartment and a cell compartment;

b) a cell reservoir in fluid communication with said cell compartment of said bioreactor, wherein said cell reservoir comprises fluid and hepatocyte spheroids in said fluid; and

c) a rocking device in contact with said cell reservoir to induce motion to said fluid,

wherein said motion results in formation of said hepatocyte spheroids in said cell reservoir and helps maintain said hepatocyte spheroids, and wherein said reservoir comprises 0.5×10 7 to 5×10 7 hepatocytes/mL of said fluid.

2. The system of claim 1 , said system further comprising an access port that provides access to said cell reservoir.

3. The system of claim 2 , wherein said access port allows a component access to said fluid in said reservoir, wherein said component is a measuring device.

4. The system of claim 1 , wherein said cell reservoir further comprises an oxygen delivering device in contact with said cell reservoir.

5. The system of claim 1 , wherein said cell reservoir further comprises a cell fluid inlet and a cell fluid outlet, wherein said cell fluid inlet and said cell fluid outlet allow said fluid to flow in or out of said cell reservoir.

6. The system of claim 1 , wherein said selectively permeable barrier comprises a bundle of hollow fibers.

7. The system of claim 1 , wherein said bioreactor further comprises a biological fluid inlet and a biological fluid outlet, wherein said biological fluid inlet and outlet permit fluid communication between said fluid treatment compartment and a bloodstream of said mammal.

8. The system of claim 5 , wherein said bioreactor further comprises a cell fluid inlet and a cell fluid outlet.

9. The system of claim 1 , said system further comprising a plurality of pumps for circulating said fluid through said cell compartment and said cell reservoir.

10. The system of claim 1 , said system further comprising an ultrafiltration cartridge in fluid communication with said cell compartment and said cell reservoir.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 5, 2008
From: MAYO FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021491/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2002
From: NYBERG, SCOTT L.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 012992/0257 →
Continuity (1)
Related Publication 20030228685A1 · Dec 11, 2003